| Advances in the production and downstream processing of antibodies JH Chon, G Zarbis-Papastoitsis New biotechnology 28 (5), 458-463, 2011 | 262 | 2011 |
| Prolonged activity of factor IX as a monomeric Fc fusion protein RT Peters, SC Low, GD Kamphaus, JA Dumont, JV Amari, Q Lu, ... Blood, The Journal of the American Society of Hematology 115 (10), 2057-2064, 2010 | 253 | 2010 |
| Antibody purification M Wan, G Avgerinos, G Zarbis-Papastoitsis US Patent 7,863,426, 2011 | 213 | 2011 |
| A singleuse purification process for the production of a monoclonal antibody produced in a PER. C6 human cell line M Kuczewski, E Schirmer, B Lain, G ZarbisPapastoitsis Biotechnology journal 6 (1), 56-65, 2011 | 126 | 2011 |
| Antibody purification M Wan, G Avgerinos, G Zarbis-Papastoitsis US Patent App. 12/882,601, 2011 | 108 | 2011 |
| Purified antibody composition MM Wan, G Avgerinos, G Zarbis-Papastoitsis US Patent 8,231,876, 2012 | 95 | 2012 |
| Purified antibody composition M Wan, G Avgerinos, G Zarbis-Papastoitsis US Patent App. 13/532,511, 2013 | 72 | 2013 |
| Design of a superior cytokine antagonist for topical ophthalmic use J Hou, SA Townson, JT Kovalchin, A Masci, O Kiner, Y Shu, BM King, ... Proceedings of the National Academy of Sciences 110 (10), 3913-3918, 2013 | 66 | 2013 |
| Development of a polishing step using a hydrophobic interaction membrane adsorber with a PER.C6®derived recombinant antibody M Kuczewski, N Fraud, R Faber, G ZarbisPapastoitsis Biotechnology and bioengineering 105 (2), 296-305, 2010 | 57 | 2010 |
| Purified antibody composition MM Wan, G Avgerinos, G Zarbis-Papastoitsis US Patent 8,916,153, 2014 | 54 | 2014 |
| Purified antibody composition MM Wan, G Avgerinos, G Zarbis-Papastoitsis US Patent 8,883,156, 2014 | 54 | 2014 |
| Purified antibody composition M Wan, G Avgerinos, G Zarbis-Papastoitsis US Patent 8,906,372, 2014 | 53 | 2014 |
| Purified antibody composition M Wan, G Avgerinos, G Zarbis-Papastoitsis US Patent 8,895,009, 2014 | 53 | 2014 |
| Development of a high-capacity Mab capture step based on cation-exchange chromatography B Lain, MA Cacciuttolo, G Zarbis-Papastoitsis Bioprocess Int 7 (5), 26-34, 2009 | 49 | 2009 |
| Primary clarification of very high-density cell culture harvests by enhanced cell settling EB Schirmer, M Kuczewski, K Golden, B Lain, C Bragg, J Chon, ... BioProcess Int 8 (1), 32-39, 2010 | 34 | 2010 |
| Purified antibody composition MM Wan, G Avgerinos, G Zarbis-Papastoitsis US Patent 9,102,723, 2015 | 26 | 2015 |
| A phase 2 exploratory study of a novel interleukin-1 receptor inhibitor (EBI-005) in the treatment of moderate-to-severe allergic conjunctivitis MH Goldstein, KL Tubridy, J Agahigian, E Furfine, M Magill, J Kovalchin, ... Eye & contact lens 41 (3), 145-155, 2015 | 23 | 2015 |
| Hydrophobic membrane adsorbers for large-scale downstream processing N Fraud, M Kuczewski, G Zarbis-Papastoitsis, M Hirai Advanstar Communications Inc., 2009 | 23 | 2009 |
| Purified antibody composition MM Wan, G Avgerinos, G Zarbis-Papastoitsis US Patent 9,096,666, 2015 | 20 | 2015 |
| Purified antibody composition MM Wan, G Avgerinos, G Zarbis-Papastoitsis US Patent 9,328,165, 2016 | 18 | 2016 |
